Clinical Trial Update: An Extension of Istradefylline in North American Parkinson's Disease Patients Who Have Completed Study 6002-INT-001 [Phase 3]

View source ↗

Summary

Phase 3 extension trial of istradefylline in North American Parkinson's disease patients who completed a prior study was terminated; results were posted in 2013…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Nourianz (istradefylline)

Snippet

Sponsor: Kyowa Kirin, Inc. | Conditions: Parkinson's Disease | Phase 3 | Status: TERMINATED | Results posted: 2013-07-30